CCIA
BEAT

Campbell & Co Investment Adviser’s BioTelemetry, Inc. BEAT Stock Holding History

Campbell & Co Investment Adviser’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6,374
Closed -$307K – 842
2019
Q2 		$307K Buy
+6,374
New +$335K 0.14% 303
2017
Q3 		– Sell
-6,921
Closed -$232K – 517
2017
Q2 		$232K Buy
+6,921
New +$206K 0.22% 217
2016
Q4 		– Sell
-10,058
Closed -$187K – 240
2016
Q3 		$187K Sell
10,058
-2,563
-20% -$48.3K 0.5% 99
2016
Q2 		$206K Buy
12,621
+411
+3% +$6.05K 1.04% 52
2016
Q1 		$143K Buy
+12,210
New +$136K 0.53% 99

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Campbell & Co Investment Adviser's BEAT Position: Q3 2019 in Review

Campbell & Co Investment Adviser sold out of BioTelemetry, Inc. (BEAT) in Q3 2019, closing a stake of 6,374 shares — an estimated $307K sold.

Campbell & Co Investment Adviser first reported a position in BEAT in Q1 2016 and held it in 5 quarters. The position peaked at $307K in Q2 2019. 219 funds tracked by Wall St. Rank hold BEAT as of Q3 2019.

  • Campbell & Co Investment Adviser reported no remaining BioTelemetry, Inc. position as of Q3 2019 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 6,374 BioTelemetry, Inc. shares in Q3 2019, an estimated $307K.
  • Campbell & Co Investment Adviser first reported a position in BioTelemetry, Inc. in Q1 2016 and held it in 5 quarters.
  • Campbell & Co Investment Adviser's BioTelemetry, Inc. position peaked at $307K in Q2 2019.
  • 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2019.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2019, filed 16 Oct 2019.